Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-09-30

Clinical Trial Update: Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients

View source ↗

Summary

A completed clinical trial evaluating SPF30 sunscreen and an after-sun lotion in individuals at risk for skin cancer, including those with Xeroderma pigmentosum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • After-sun lotion
  • SPF30 Sunscreen

Snippet

Sponsor: Medical University of Graz | Conditions: Skin Cancer, Xeroderma Pigmentosum | Status: COMPLETED